CClinicalTrials.gg
Active, not recruitingNCT05360108DAAP-PRUpdated Mar 16, 2026

Screening for Abdominal Aortic Aneurysm and Popliteal Artery Aneurysm

An observational study in Aortic Aneurysm, Abdominal and Popliteal Artery Aneurysm, sponsored by Centre Hospitalier Universitaire Vaudois. Active, not recruiting at 5 sites in 2 countries. Open to participants aged 55 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-03-16.

Sponsored by Centre Hospitalier Universitaire Vaudois · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
507
Ages
55 Years to 85 Years
Sex
All
01

Study summary

Observational, prospective, cohort study to evaluate, by an opportunistic screening program based on vascular ultrasound, the prevalence and characteristics of Abdominal Aortic Aneurysm (AAA) and Popliteal Artery Aneurysm (PAA) in a female population as well as the prevalence and characteristics of PAA in male population.

Read the detailed description

Abdominal aortic aneurysm (AAA) remains a highly topical issue given the potentially dramatic consequences associated with its rupture. In men, the prevalence of AAA is declining, probably due to improved management of risk factors. However, the most recent studies and international recommendations have reaffirmed that screening for AAA in men is still important and cost-effective. In contrast, data regarding the risk and characteristics of AAA in women are very limited and outdated. For this reason, the recommendations are contrasting and not univocal. About 35% of patients with AAA have a second aneurysm more distally. Popliteal artery aneurysm (PAA) is the most common. Like AAA, PAA is often asymptomatic and its main complication is thrombotic occlusion resulting in acute/chronic ischemia of the affected limb and a high prevalence of permanent sequelae (mainly amputation). Data on epidemiology and risk factors of PAA are very limited in men and absent in women. In addition, the benefit of PAA screening has never been assessed so far.

The aim of this study is to evaluate, by an opportunistic screening program based on vascular ultrasound, the prevalence and characteristics of AAA and PAA in a female population as well as the prevalence and characteristics of PAA in male population. The project represents the first screening program for popliteal aneurysm. Finally, the results will allow us to better assess need for and modalities of a screening program.

02

Conditions studied

  • Aortic Aneurysm, Abdominal
  • Popliteal Artery Aneurysm

Keywords

  • Abdominal aortic aneurysm
  • Popliteal aneurysm
  • Screening
03

In context

Aortic Aneurysm, Abdominal

473 studies on the registry are indexed under Aortic Aneurysm, Abdominal; 100 are open to participants now.

This study's enrollment of 507 is above the median of 166 across 220 observational studies indexed under Aortic Aneurysm, Abdominal.

Browse Aortic Aneurysm, Abdominal studies →

Lead sponsor

Centre Hospitalier Universitaire Vaudois is the lead sponsor of 203 studies on the registry; 47 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Women or Men at high risk for aneurysmal disease

Inclusion criteria

  • Women aged ≥65 years who are current smokers
  • Men aged ≥65 years
  • Women or Men aged ≥55 years with family history (first-degree relatives) for Abdominal Aortic Aneurysm (AAA) or popliteal artery aneurysm (PAA)

Exclusion criteria

Exclusion Criteria:

  • Patient with known diagnosis of AAA or PAA
  • Patient already operated for AAA or PAA
  • AAA/PAA screening or arterial assessment of lower limbs within the last 12 months
  • Inability to understand and/or sign study consent
  • Inability to access follow-up controls
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
507 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Abdominal aortic measurement

    Ultrasound of infrarenal aorta with diameter measured in mm

    Time frame: 1 day

  2. Popliteal artery measurement

    Ultrasound of popliteal artery with diameter measured in mm

    Time frame: 1 day

Secondary outcomes

  1. Smoking habits

    Defined by active smoking, former smoking, never smoking

    Time frame: 1 day

  2. Other cardiovascular risk factors

    Arterial hypertension, Diabetes, Dyslipidemia, Obesity

    Time frame: 1 day

  3. History of cardiovascular diseases

    Coronary artery disease, cerebrovascular disease, lower extremity peripheral artery disease, venous thromboembolism

    Time frame: 1 day

  4. Family history for aneurysmal disease

    First-degree relatives with aneurysmal disease

    Time frame: 1 day

  5. Time-consuming

    Time needed to perform screening

    Time frame: 1 day

  6. Surgical intervention for aneurysm

    Number of aneurysm operated during follow-up

    Time frame: 36 months

07

Study locations

5 sites
  • Ospedale di Castelfranco Veneto, AULSS 2 Marca Trevigiana, Via dei Carpani 16/Z
    Castelfranco Veneto, TV I-31033, Italy
  • UOC Clinica Medica 1, Azienda Ospedale - Università di Padova, Via Nicolò Giustiniani 2
    Padova, I-35128, Italy
  • UOSD Percorso Trombosi. Dipartimento di Scienze dell'Invecchiamento, Ortopediche e Reumatologiche. Fondazione Policlinico Universitario A. Gemelli IRCCS. Largo Agostino Gemelli 8
    Roma, I-00168, Italy
  • UOS Angiologia Medica, Ospedale di Rovigo ULSS 5 Polesana, Viale Tre Martiri 140
    Rovigo, I-45100, Italy
  • Centre Hospitalier Universitaire Vaudois (CHUV), Service d'Angiologie
    Lausanne, Canton of Vaud 1011, Switzerland
08

References and documents

Publications

  • Chaikof EL, Dalman RL, Eskandari MK, Jackson BM, Lee WA, Mansour MA, Mastracci TM, Mell M, Murad MH, Nguyen LL, Oderich GS, Patel MS, Schermerhorn ML, Starnes BW. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg. 2018 Jan;67(1):2-77.e2. doi: 10.1016/j.jvs.2017.10.044. PubMed 29268916 ↗
  • Wanhainen A, Verzini F, Van Herzeele I, Allaire E, Bown M, Cohnert T, Dick F, van Herwaarden J, Karkos C, Koelemay M, Kolbel T, Loftus I, Mani K, Melissano G, Powell J, Szeberin Z, Esvs Guidelines Committee, de Borst GJ, Chakfe N, Debus S, Hinchliffe R, Kakkos S, Koncar I, Kolh P, Lindholt JS, de Vega M, Vermassen F, Document Reviewers, Bjorck M, Cheng S, Dalman R, Davidovic L, Donas K, Earnshaw J, Eckstein HH, Golledge J, Haulon S, Mastracci T, Naylor R, Ricco JB, Verhagen H. Editor's Choice - European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms. Eur J Vasc Endovasc Surg. 2019 Jan;57(1):8-93. doi: 10.1016/j.ejvs.2018.09.020. Epub 2018 Dec 5. No abstract available. PubMed 30528142 ↗
  • Svensjo S, Mani K, Bjorck M, Lundkvist J, Wanhainen A. Screening for abdominal aortic aneurysm in 65-year-old men remains cost-effective with contemporary epidemiology and management. Eur J Vasc Endovasc Surg. 2014 Apr;47(4):357-65. doi: 10.1016/j.ejvs.2013.12.023. Epub 2014 Jan 31. PubMed 24485841 ↗
  • Farber A, Angle N, Avgerinos E, Dubois L, Eslami M, Geraghty P, Haurani M, Jim J, Ketteler E, Pulli R, Siracuse JJ, Murad MH. The Society for Vascular Surgery clinical practice guidelines on popliteal artery aneurysms. J Vasc Surg. 2022 Jan;75(1S):109S-120S. doi: 10.1016/j.jvs.2021.04.040. Epub 2021 May 20. PubMed 34023430 ↗
  • Aboyans V, Bataille V, Bliscaux P, Ederhy S, Filliol D, Honton B, Kurtz B, Messas E, Mohty D, Brochet E, Kownator S; investigators of the E2T3A study. Effectiveness of screening for abdominal aortic aneurysm during echocardiography. Am J Cardiol. 2014 Oct 1;114(7):1100-4. doi: 10.1016/j.amjcard.2014.07.024. Epub 2014 Jul 18. PubMed 25127549 ↗
  • Matsumura Y, Ochi Y, Wada M, Hirakawa D, Yamanaka S, Kamioka M, Kitaoka H, Orihashi K, Nakaoka Y, Doi Y, Sugiura T. Usefulness of Screening for Abdominal Aortic Aneurysm During Transthoracic Echocardiography in Women >/=50 Years of Age. Am J Cardiol. 2018 Dec 15;122(12):2147-2150. doi: 10.1016/j.amjcard.2018.08.050. Epub 2018 Sep 22. PubMed 30360889 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05360108
Lead sponsor
Centre Hospitalier Universitaire Vaudois
Responsible party
Adriano Alatri (MD, Senior Physician, Centre Hospitalier Universitaire Vaudois) — Principal investigator
First posted
May 4, 2022
Start date
Jun 1, 2020
Primary completion
Feb 23, 2026
Completion
Jun 30, 2029 (estimated)
Last update
Mar 16, 2026

Study contacts

Lucia Mazzolai, MD, PhD
study chair · Centre Hospitalier Universitaire Vaudois
Adriano Alatri, MD
principal investigator · Centre Hospitalier Universitaire Vaudois

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion